D-1082-2023 Class III Terminated

Recalled by SUN PHARMACEUTICAL INDUSTRIES INC — Princeton, NJ

Recall Details

Product Type
Drugs
Report Date
August 16, 2023
Initiation Date
July 18, 2023
Termination Date
February 26, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
360 60-count bottles

Product Description

Dofetilide Capsules 500 mcg (0.5mg), 60-count bottle, Rx Only, Manufactured by Sun Pharmaceutical Industries Limited, Survey No. 259/15, Dadra-396 191, (U.T of D & NH), India, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512. NDC 47335-063-86

Reason for Recall

Out of Specification result observed in content uniformity testing

Distribution Pattern

Nationwide in the USA

Code Information

Lot: DNE0217A, Exp 01/2025